These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3513269)

  • 1. Effects of beta-agonists on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease.
    Papiris S; Galavotti V; Sturani C
    Respiration; 1986; 49(2):101-8. PubMed ID: 3513269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clenbuterol and salbutamol in the symptomatic treatment of patients with reversible airways obstruction.
    Jaffé G; Grimshaw JJ
    Pharmatherapeutica; 1983; 3(7):492-5. PubMed ID: 6366806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.
    Belman MJ; Botnick WC; Shin JW
    Am J Respir Crit Care Med; 1996 Mar; 153(3):967-75. PubMed ID: 8630581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of arterial oxygen desaturation on six minute walk distance, perceived effort, and perceived breathlessness in patients with airflow limitation.
    Mak VH; Bugler JR; Roberts CM; Spiro SG
    Thorax; 1993 Jan; 48(1):33-8. PubMed ID: 8434350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison between inhaled clenbuterol and salbutamol in chronic bronchitis with reversible airway obstruction.
    Baronti A; Grieco A; Vibelli C
    Eur J Respir Dis; 1980 Jun; 61(3):143-50. PubMed ID: 7002574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breathlessness and exercise tolerance in chronic airflow obstruction: 2-hourly versus 4-hourly salbutamol by inhalation.
    Shah SS; Johnston D; Woodcock AA; Johnson M; Geddes DM
    Curr Med Res Opin; 1983; 8(5):345-9. PubMed ID: 6340975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NAB 365 (clenbuterol) and salbutamol in asthmatics: a double-blind clinical trial.
    Pasotti C; Capra A; Vibelli C
    Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):176-80. PubMed ID: 376459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease.
    Nisar M; Walshaw M; Earis JE; Pearson MG; Calverley PM
    Thorax; 1990 Mar; 45(3):190-4. PubMed ID: 2330551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxygen desaturation and breathlessness during corridor walking in chronic obstructive pulmonary disease: effect of oxitropium bromide.
    Spence DP; Hay JG; Carter J; Pearson MG; Calverley PM
    Thorax; 1993 Nov; 48(11):1145-50. PubMed ID: 8296259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of beta 2-adrenoceptor agonists on plasma potassium and cardiopulmonary responses on exercise in patients with chronic obstructive pulmonary disease.
    Yang CT; Lin HC; Lin MC; Wang CH; Lee CH; Kuo HP
    Eur J Clin Pharmacol; 1996; 49(5):341-5. PubMed ID: 8866625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchodilator response to nebulized salbutamol in elderly patients with stable chronic airflow limitation.
    Geraghty R; Foster C; Black D; Roe S
    Respir Med; 1993 Jul; 87(5):375-8. PubMed ID: 8209057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aerosolized clenbuterol (NAB 365) and salbutamol in exercise-induced asthma.
    Del Bono N; Quartieri F; Vibelli C
    Curr Med Res Opin; 1979; 6(4):237-43. PubMed ID: 527347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of nebulized fenoterol on spirometry, dyspnea sensation changes during exercise in patients with chronic obstructive pulmonary disease.
    Chiang LL; Yu CT; Kuo HP
    Changgeng Yi Xue Za Zhi; 1996 Jun; 19(2):129-34. PubMed ID: 8828254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A trial of clenbuterol in bronchial asthma.
    Anderson G; Wilkins E
    Thorax; 1977 Dec; 32(6):717-9. PubMed ID: 341407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of domiciliary nebulizers in managing patients with severe COPD.
    Eiser N; Angus K; McHale S
    Respir Med; 2001 Apr; 95(4):265-74. PubMed ID: 11316108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind cross-over comparison of clenbuterol and salbutamol tablets in asthmatic out-patients.
    Salorinne Y; Stenius B; Tukiainen P; Poppius H
    Eur J Clin Pharmacol; 1975 Apr; 8(3-4):189-95. PubMed ID: 9295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of nebulized salbutamol on lung function and exercise tolerance in patients with severe airflow obstruction.
    Connellan SJ; Gough SE
    Br J Dis Chest; 1982 Apr; 76(2):135-42. PubMed ID: 7093130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral NAB 365 (clenbuterol) and terbutaline in chronic obstructive lung disease: a double-blind, two-week study.
    Baronti A; Grieco A; Vibelli C
    Int J Clin Pharmacol Ther Toxicol; 1980 Jan; 18(1):21-5. PubMed ID: 6988343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atropine methonitrate and salbutamol in chronic airways obstruction: peak effect and duration of action.
    Starke ID; Parker RA; Turner-Warwick M
    Respiration; 1982; 43(1):51-6. PubMed ID: 7089390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the protective effect and duration of action of orally administered clenbuterol and salbutamol on exercise-induced asthma in children.
    Boner AL; Vallone G; Brighenti C; Schiassi M; Miglioranzi P; Richelli C
    Pediatr Pulmonol; 1988; 4(4):197-200. PubMed ID: 3393382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.